Vision RT

Executive Summary

Vision RT is the pioneer and global leader in Surface Guided Radiation Therapy (SGRT), offering non-invasive 3D surface imaging systems that enhance the precision, safety, and efficiency of radiotherapy. Founded in 2001 and headquartered in London, the company's technology is deployed in leading cancer centers worldwide, enabling real-time patient positioning and motion tracking without ionizing radiation. As radiotherapy increasingly adopts motion management and hypofractionation, Vision RT's solutions are becoming standard of care. The company is well-positioned to benefit from the expanding global radiotherapy market, driven by rising cancer incidence and technological advancements. However, as a private firm, its financials and growth trajectory are not publicly disclosed, and it faces competition from other SGRT providers and alternative motion management technologies.

Upcoming Catalysts (preview)

• Q2 2026FDA clearance for next-generation SGRT system with enhanced features80% success
• Q4 2026Strategic partnership with a major radiotherapy OEM to embed SGRT technology60% success
• Q3 2026Publication of pivotal clinical study demonstrating improved outcomes with SGRT-guided stereotactic treatments70% success